Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | STK10 | O94804 | 1/20 | 0.32 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.32 |
| ▸ | ATR | Q13535 | 1/20 | 0.31 |
| ▸ | ATRIP | Q8WXE1 | 1/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10262628 | 0.98 | KDM4E (0.32) | KDM4EALDH1A1MAPTHTTSTK10 | |
| SCHEMBL12205490 | 0.98 | KDM4E (0.32) | KDM4EALDH1A1MAPTHTTSTK10 | |
| SCHEMBL13868716 | 0.95 | KDM4E (0.31) | KDM4EALDH1A1MAPTHTTSTK10 | |
| SCHEMBL13868712 | 0.95 | KDM4E (0.34) | KDM4EALDH1A1MAPTHTTATR | |
| SCHEMBL13868628 | 0.94 | PRKDC (0.34) | KDM4EALDH1A1MAPTHTTSTK10 | |
| SCHEMBL13868685 | 0.94 | PRKDC (0.34) | KDM4EALDH1A1MAPTHTTSTK10 | |
| SCHEMBL10292860 | 0.94 | PRKDC (0.34) | KDM4EALDH1A1MAPTHTTSTK10 | |
| SCHEMBL13868686 | 0.93 | PRKDC (0.34) | KDM4EALDH1A1MAPTSTK10SLK | |
| SCHEMBL10261675 | 0.93 | ATR (0.31) | ATRATRIP | |
| SCHEMBL13868669 | 0.93 | TTK (0.33) | KDM4EALDH1A1MAPTHTTSTK10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240241291-A1 | FUNCTIONAL LAMINATE AND FUNCTIONAL LENS COMPRISING THE FUNCTIONAL LAMINATE | TOKUYAMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20230272252-A1 | ADHESIVE COMPOSITION, LAMINATE AND OPTICAL ARTICLE COMPRISING THE LAMINATE | TOKUYAMA CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| EP-3345954-B1 | POLYROTAXANE, PRODUCTION METHOD THEREFOR, AND OPTICAL COMPOSITION CONTAINING SAID POLYROTAXANE | TOKUYAMA CORP (JP) | 2023-07-05 | — | — | EP | disclosed |
| US-11649327-B2 | Photochromic curable composition, use thereof, and polyrotaxane monomers | TOKUYAMA CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| US-11578174-B2 | Polyrotaxane, production method therefor, and optical composition containing said polyrotaxane | TOKUYAMA CORPORATION (JP) | 2023-02-14 | — | — | US | disclosed |
| US-20220162486-A1 | PHOTOCHROMIC OPTICAL ARTICLE AND METHOD FOR MANUFACTURING SAME | TOKUYAMA CORPORATION (JP) | 2022-05-26 | — | — | US | disclosed |
| EP-3950624-A1 | PHOTOCHROMIC OPTICAL ARTICLE AND METHOD FOR MANUFACTURING SAME | Tokuyama Corporation (JP) | 2022-02-09 | — | — | EP | disclosed |
| EP-3330751-B1 | METHOD OF PRODUCING A PHOTOCHROMIC LAMINATE | TOKUYAMA CORP (JP) | 2021-05-26 | — | — | EP | disclosed |
| EP-3399368-B1 | LAMINATE AND OPTICAL ARTICLE USING SAID LAMINATE | TOKUYAMA CORP (JP) | 2021-02-24 | — | — | EP | disclosed |
| US-20210002545-A1 | PHOTOCHROMIC CURABLE COMPOSITION | TOKUYAMA CORPORATION (JP) | 2021-01-07 | — | — | US | disclosed |
| WO-2012018070-A1 | PHOTOCHROMIC COMPOSITION | 株式会社トクヤマ (JP) | 2012-02-09 | — | — | WO | disclosed |
| US-20110062396-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| EP-2275418-A1 | CHROMENE COMPOUND | Tokuyama Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-7521004-B2 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| US-7521004-B2 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| EP-1674460-B1 | CHROMENE COMPOUND | TOKUYAMA CORP (JP) | 2009-01-21 | — | — | EP | disclosed |
| US-20080058444-A1 | Polymerization Curable Composition | TOKUYAMA CORPORATION (JP) | 2008-03-06 | — | — | US | disclosed |
| US-20070215844-A1 | Chromene Compound | TOKUYAMA CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070215844-A1 | Chromene Compound | TOKUYAMA CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| EP-1810982-A1 | POLYMERIZATION-CURABLE COMPOSITION | Tokuyama Corporation (JP) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070215844-A1 | Chromene Compound | CRY2, TYR, CRY1 | KDM4E 1354/4885ALDH1A1 2110/4885MAPT 520/4885 |
| US-20110062396-A1 | CHROMENE COMPOUND | CDYL, NR0B1, NR1H2 | KDM4E 2629/4885ALDH1A1 1987/4885MAPT 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.